ATE130008T1 - Für oligodendrocyten cytotoxischer faktor. - Google Patents

Für oligodendrocyten cytotoxischer faktor.

Info

Publication number
ATE130008T1
ATE130008T1 AT90116388T AT90116388T ATE130008T1 AT E130008 T1 ATE130008 T1 AT E130008T1 AT 90116388 T AT90116388 T AT 90116388T AT 90116388 T AT90116388 T AT 90116388T AT E130008 T1 ATE130008 T1 AT E130008T1
Authority
AT
Austria
Prior art keywords
oligodendrocytes
cytotoxic factor
factor
homologs
fragments
Prior art date
Application number
AT90116388T
Other languages
English (en)
Inventor
Michal Schwartz
Avi Cohen
Original Assignee
Yeda Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yeda Res & Dev filed Critical Yeda Res & Dev
Application granted granted Critical
Publication of ATE130008T1 publication Critical patent/ATE130008T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/60—Fish, e.g. seahorses; Fish eggs
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1025—Acyltransferases (2.3)
    • C12N9/104—Aminoacyltransferases (2.3.2)
    • C12N9/1044—Protein-glutamine gamma-glutamyltransferase (2.3.2.13), i.e. transglutaminase or factor XIII
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/22—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Wood Science & Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Neurosurgery (AREA)
  • Marine Sciences & Fisheries (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Neurology (AREA)
  • Toxicology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT90116388T 1989-08-28 1990-08-27 Für oligodendrocyten cytotoxischer faktor. ATE130008T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL91459A IL91459A0 (en) 1989-08-28 1989-08-28 Oligodendrocyte inhibitory factor

Publications (1)

Publication Number Publication Date
ATE130008T1 true ATE130008T1 (de) 1995-11-15

Family

ID=11060333

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90116388T ATE130008T1 (de) 1989-08-28 1990-08-27 Für oligodendrocyten cytotoxischer faktor.

Country Status (16)

Country Link
EP (1) EP0415321B1 (de)
JP (1) JPH0411896A (de)
KR (1) KR910004200A (de)
AT (1) ATE130008T1 (de)
CA (1) CA2024030A1 (de)
DE (1) DE69023433T2 (de)
DK (1) DK0415321T3 (de)
ES (1) ES2081884T3 (de)
FI (1) FI904229A7 (de)
GR (1) GR3018534T3 (de)
HU (1) HUT56117A (de)
IE (1) IE903108A1 (de)
IL (1) IL91459A0 (de)
NZ (1) NZ235059A (de)
PT (1) PT95123A (de)
ZA (1) ZA906853B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL97365A0 (en) * 1991-02-27 1992-05-25 Yeda Res & Dev Pharmaceutical compositions comprising a lymphokine
IE911318A1 (en) * 1990-04-23 1991-10-23 Yeda Res & Dev Use of a tumor necrosis factor for facilitating nerve¹regeneration
CN1084888A (zh) * 1992-07-30 1994-04-06 耶达研究及发展有限公司 由酶促反应制备的二聚il-2以及用于制备该il-2的源于神经的转谷氨酰胺酶
US6267955B1 (en) 1995-09-15 2001-07-31 Yeda Research And Development Co. Ltd. Mononuclear phagocytes and their use to promote axonal regeneration
US5800812A (en) * 1995-09-15 1998-09-01 Yeda Research And Development Co. Ltd. Methods of use of mononuclear phagocytes to promote axonal regeneration

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL71440A0 (en) * 1984-04-04 1984-07-31 Univ Ramot Composition for nerve regeneration
IL87349A (en) * 1988-08-04 1994-06-24 Michal Schwartz Water-soluble factor that activates glial cells, its preparation and pharmaceutical compositions comprising it

Also Published As

Publication number Publication date
AU642897B2 (en) 1993-11-04
HUT56117A (en) 1991-07-29
ES2081884T3 (es) 1996-03-16
CA2024030A1 (en) 1991-03-01
PT95123A (pt) 1991-05-22
FI904229A7 (fi) 1991-03-01
IE903108A1 (en) 1991-03-13
ZA906853B (en) 1991-06-26
DE69023433D1 (de) 1995-12-14
IL91459A0 (en) 1990-04-29
DK0415321T3 (da) 1995-12-27
EP0415321A1 (de) 1991-03-06
NZ235059A (en) 1992-09-25
GR3018534T3 (en) 1996-03-31
KR910004200A (ko) 1991-03-28
AU6137290A (en) 1991-02-28
EP0415321B1 (de) 1995-11-08
HU905507D0 (en) 1991-02-28
DE69023433T2 (de) 1996-04-04
JPH0411896A (ja) 1992-01-16
FI904229A0 (fi) 1990-08-27

Similar Documents

Publication Publication Date Title
ATE196089T1 (de) Mittel zur hemmung des komplementsystems hergestellt aus fucanen aus braunen algen
GR3035682T3 (en) Non-glycosylated fgf-4 and compositions containing the same.
ES2054723T3 (es) Tetrahidropiridinoximas, procedimiento para su preparacion y uso de las mismas como agentes colinergicos.
IL85627A (en) Pharmaceutical compositions for treatment of disorders of ischemic origin comprising metformin and its salts
EP0296573A3 (en) Novel nucleosides, their preparation and pharmaceutical novel nucleosides, their preparation and pharmaceutical compositions compositions
PT89249A (pt) Processo para a preparacao de novos derivados de piperidinilo 1,4-dissubstituido com actividade terapeutica
DE69023433D1 (de) Für Oligodendrocyten cytotoxischer Faktor.
HU896609D0 (en) Process for the preparation of pharmaceutical compositions containing compounds having nootropic activity
DE3887068D1 (de) 2,2-Dimethylchromenderivate, Verfahren zur Herstellung und diese enthaltende pharmazeutische Zusammenstellungen.
GR3015052T3 (en) Antibiotic GE 2270 factors A1, A2, A3 and H.
DK0443848T3 (da) Nyt antiulcermiddel
ATE64300T1 (de) Wirkstoffe zur anwendung bei der behandlung von tumoren.
PT90816A (pt) Processo para a preparacao de composicoes farmaceuticas contendo analogos de 2',5'-oligoadenilato
ES2111561T3 (es) Derivados de benzopirano antihipertensivos.
PT88254A (pt) Processo para a preparacao de derivados de eritromicina a modificada em c.12
MY130049A (en) Oligodendrocyte cytotoxic factor.
NZ224502A (en) Silyl alkylene amines and pharmaceutical use, methods for preparation and the treatment of non humans
PT91415A (pt) Processo para a preparacao de novos derivados de furiltiazol
EP0388977A3 (de) Polycyclische Amine zur Verwendung als Zerebrovaskulärer Wirkstoff
PT84405B (pt) Processo para a preparacao de composicoes farmaceuticas contendo 2-alcoxi-n-(1-azabiciclo {2.2.2} octil-3-benzamida-n-oxidos apropriadas para controlar a emese provocada por drogas anti-cancro
PT95566A (pt) Metodo para a utilizacao de derivados de 2-oxindole substituidos na posicao 3 como inibidores da biossintese de interleuquina-1
ATE80873T1 (de) Tetrahydropyridin-derivate.
PT93822A (pt) Processo para a preparacao de derivados de piridina
BR9714184A (pt) Utilização de bonzoillquil-1,2,3,6-tetraidropiridinas
DE68909399D1 (de) Verwendung von Gangliosiden zur Behandlung der Dysfunktion des autonomen Nervensystems bei der Chagas-Krankheit.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee